EXICURE, INC. Debt Securities, Available-for-sale
EXICURE, INC. (XCUR) had Debt Securities, Available-for-sale of $0 as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-03-25
- 2025-12-31: Debt Securities, Available-for-sale $0.00.
- 2024-12-31: Debt Securities, Available-for-sale $0.00.
- 2024-09-30: Debt Securities, Available-for-sale $0.00.
- 2024-06-30: Debt Securities, Available-for-sale $0.00.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-25 |
| 2024-12-31 | $0.00 10-K · filed 2025-03-18 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 |
| 2024-03-31 | $0.00 10-Q · filed 2024-06-17 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-18 |
| 2023-09-30 | $0.00 10-Q · filed 2024-05-16 |
| 2023-06-30 | $2.00M 10-Q/A · filed 2024-06-06 |
| 2022-12-31 | $0.00 10-Q/A · filed 2024-06-06 |
| 2021-12-31 | $10.50M 10-K · filed 2023-03-27 |
| 2021-09-30 | $8.95M 10-Q · filed 2021-11-19 |
| 2021-06-30 | $13.47M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $33.14M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $48.82M 10-K · filed 2022-03-25 |
| 2020-09-30 | $62.62M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $68.58M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $74.22M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $64.82M 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |